Gantz N M, Myerowitz R L, Medeiros A A, Carrera G F, Wilson R E, O'Brien T F
Am J Med. 1975 May;58(5):637-43. doi: 10.1016/0002-9343(75)90499-4.
Bactermia due to listeria monocytogenes developed in eight patients who were receiving immunosuppresive medications during a 15 month period at one hospital. Seven survived. Meningitis was documented in only the four who received kidney transplants. Their neurologic signs were minimal, indicating a need to treat any immunosuppressed patient with Listeria bacteremia for meningitis. During this period the incidence of Listeria bactermia in immunosuppressed patients greatly exceeded that previously observed in this hospital or reported elsewhere, but the incidence of infection with other opportunistic agents was not increased. As with previously decreased listeria outbreaks in nonimmunosuppressed patients, no source or mechanism of spread could be identified. Thus, disease due to L. monocytogenes may occur focally among immunosuppressed populations, a pattern which also appears to be emerging for other opportunistic agents. A patient's exposure to different opportunistic agents may be as important as the kind of immunosuppressive therapy he recieves in determining which opportunistic infection he will acquire or even whether any infection will occur.
在一家医院的15个月期间,8名正在接受免疫抑制药物治疗的患者发生了由单核细胞增生李斯特菌引起的菌血症。7人存活。仅4名接受肾移植的患者发生了脑膜炎。他们的神经体征轻微,这表明对于任何患有李斯特菌菌血症的免疫抑制患者都有必要针对脑膜炎进行治疗。在此期间,免疫抑制患者中李斯特菌菌血症的发生率大大超过了该医院先前观察到的或其他地方报道的发生率,但其他机会性病原体的感染率并未增加。与之前非免疫抑制患者中李斯特菌暴发减少的情况一样,无法确定传播源或传播机制。因此,单核细胞增生李斯特菌引起的疾病可能在免疫抑制人群中局部发生,这种模式似乎也正在出现在其他机会性病原体中。在确定患者将获得哪种机会性感染甚至是否会发生任何感染时,患者接触不同的机会性病原体可能与他接受的免疫抑制治疗类型同样重要。